Helix BioPharma Corp. Announces Delay of Annual Filings : vi

RICHMOND HILL, ON / ACCESSWIRE / October 15, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment

Related Keywords

Canada , Toronto , Ontario , Richmond Hill , Canadian , Frank Michalargias , Pascal Nigen , National Instrument , Alpha Bronze , Toronto Stock Exchange , Ontario Securities Commission , Helix Biopharma Corp , Helix Biopharma , Disclosure Obligations , Interim Filings , Annual Filings , National Policy , Cease Trade Orders , Ontario Securities , Alternative Information Guidelines , Chief Financial , Looking Statements , Filing Deadline , Annual Information Form , Helix , Iopharma , Orp , Nnounces , Delay , Nnual , Filings ,